Related Experiment Video
Updated: Feb 2, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Involvement of miRNA polymorphism in mucositis development in childhood acute lymphoblastic leukemia treatment
Ángela Gutierrez-Camino1,2, Maitane Umerez1, Elixabet Lopez-Lopez1,2
1Department of Genetics, Physic Anthropology & Animal Physiology, University of the Basque Country, UPV/EHU, Leioa, 48940, Spain.
Aim:
Mucositis, linked to methotrexate, daunorubicin or cyclophosphamide, is a frequent childhood acute lymphoblastic leukemia (ALL) therapy side effect. miRNAs regulate the expression of pharmacokinetic/pharmacodynamic pathway genes. SNPs in miRNAs could affect their levels or function, and affect their pharmacokinetic/pharmacodynamic pathway target genes. Our aim was to determine the association between miRNA genetic variants targeting mucositis-related genes and mucositis-developing risk.
Patients & Methods:
We analyzed 160 SNPs in 179 Spanish children with B-cell precursor ALL homogeneously treated with LAL/SHOP protocols.
Results:
We identified three SNPs in miR-4268, miR-4751 and miR-3117 associated with mucositis, diarrhea and vomiting, respectively.
Conclusion:
The effect of these SNPs on genes related to drug pharmacokinetics/pharmacodynamics could explain mucositis, diarrhea and vomiting development during ALL therapy.
Insights
Genetic variants in microRNAs (miRNAs) are associated with mucositis and other side effects in children undergoing acute lymphoblastic leukemia (ALL) therapy. These single nucleotide polymorphisms (SNPs) may influence drug response and toxicity.
Area of Science:
- Genetics
- Pediatric Oncology
- Pharmacogenomics
Background:
- Mucositis is a common side effect of chemotherapy for childhood acute lymphoblastic leukemia (ALL).
- MicroRNAs (miRNAs) play a role in regulating genes involved in drug metabolism and response.
- Single nucleotide polymorphisms (SNPs) in miRNAs could alter their function and impact treatment outcomes.
Purpose of the Study:
- To investigate the association between miRNA genetic variants and the risk of developing mucositis in children with ALL.
- To explore the potential role of miRNA SNPs in mediating chemotherapy-induced toxicities.
Main Methods:
- Analysis of 160 SNPs in 179 Spanish children with B-cell precursor ALL.
- Homogeneous treatment protocols (LAL/SHOP) were used.
Main Results:
- Three SNPs in miR-4268, miR-4751, and miR-3117 were significantly associated with mucositis, diarrhea, and vomiting, respectively.
- These findings suggest a genetic predisposition to specific chemotherapy side effects.
Conclusions:
- Specific miRNA genetic variants may influence the development of mucositis, diarrhea, and vomiting during ALL therapy.
- The identified SNPs could affect pharmacokinetic/pharmacodynamic pathways, explaining observed toxicities.
Related Concept Videos
Erikson's Theory on Socioemotional Development during Childhood
The first four of Erikson's eight...
Piaget's Theory of Cognitive Development from Childhood into Adulthood
Schemata: Building Blocks of Knowledge
Mucosal Barrier of the Stomach
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Single Nucleotide Polymorphisms-SNPs
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...

